This stock needs to be on your radar, again

by | Aug 23, 2022 | MYMD

 


Sponsored By


See Disclosure Below

Take note, Trader!

It has been over a week since I talked about MYMD.

As you know, I have been bullish on MyMD for some time now.

Why should you care about this tiny biotech stock?

For starters, I think that anyone 40 years old+ should be super excited about a company working on a drug attempting to slow down the aging process.

This is exactly what MyMD’s leading drug candidate MYMD-1® is in FDA Phase 2 clinical trials for – sarcopenia, to be more specific.

Sarcopenia refers to the loss of muscle tissue as a natural part of the aging process. MYMD-1® targets what is believed to be one of the main causes of sarcopenia. If successful, this drug offers the ability to potentially increase human lifespan.

Besides sarcopenia, the company is also aiming to advance MYMD-1® into a phase 2 clinical trial for treatment of diabetes, rheumatoid arthritis and multiple sclerosis at some point in the future.


On top of the drug development, MYMD is working on, traders should focus on the short-term potential here.

I think the stock has seen an overreaction to the recent financing they did (which is an excellent thing for the company’s balance sheet).

We also saw a lot of “hot money” traders flipping out of the stock after the recent 200% rally. Who can blame them for that?

Now, the technicals are firming up on the price chart and I would not be surprised to see dip buyers show up very soon.

If you have been waiting on the sidelines for a good time to start looking at MYMD again…for me, now is the time!



62 Calef Hwy #233 Lee, New Hampshire 03861 United States

Questions or concerns about our products? Email Support@360.com © Copyright 2022, RagingBull – Refund Policy – Privacy Policy – Terms & Conditions


*THIS IS AN ISSUER-PAID ADVERTISEMENT, SEE DISCLOSURE BELOW
*ISSUER-PAID ADVERTISEMENT. MyMD, Inc. (“MYMD” or the “Company”) HAS PAID OR
WILL PAY SHERWOOD VENTURES, LLC (“Sherwood”) TWENTY-THOUSAND DOLLARS USD PER MONTH FOR THREE MONTHS (THE “INITIAL TERM”) IN CASH, SHARES OF RESTRICTED COMMON STOCK WITH A VALUE OF ONE-HUNDRED-FIFTY THOUSAND DOLLARS, AND WARRANTS VALUED AT ISSUANCE OF SEVENTY-FIVE THOUSAND DOLLARS FOR MARKETING SERVICES INCLUDING COMMUNICATING TO THE PUBLIC ABOUT THE COMPANY THROUGH SHERWOOD’S AFFILIATE RAGINGBULL.COM, LLC (“RAGING BULL”), AMONG OTHERS. THIS ADVERTISEMENT IS PART OF THOSE ISSUER-PAID MARKETING SERVICES. FOR DETAILED COMPENSATION AND MORE INFORMATION, PLEASE SEE THE FULL DISCLOSURE LOCATED AT HTTPS://BOARDROOMINVESTING.COM/MYMD-DISCLAIMER.


DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer.

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.

RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.

RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of RagingBull.com, LLC are paid in whole or in part by commission based on their sales of Services to subscribers.

WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.